Magnetic Resonance Imaging After Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate Between No Residual Carcinoma and Residual Ductal Carcinoma in Situ in Patients With Triple-Negative Breast Cancer
PLoS ONE - United States
doi 10.1371/journal.pone.0149347
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 11, 2016
Authors
Publisher
Public Library of Science (PLoS)